Investing in biotech stocks is relatively risky amid the volatility of the market. There are many factors that can greatly affect share trends and price performance.

Novartis AG (ADR) (NYSE:NVS) has announced the name of three scientists for Prizes for Immunology winners, and will going to give it in the prize distribution ceremony on August 23, 2013, at 15th International Congress of Immunology in Milan, Italy.

One to keep your eye on Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and its partner Novartis AG (ADR) (NYSE:NVS) could benefit greatly from the precedence that Pfizer Inc. (NYSE:PFE) and Takeda have set.

That includes Novartis AG (ADR) (NYSE:NVS) LDK378, a next-generation ALK inhibitor that was awarded breakthrough status in March amid Phase II trials.

This YLG initiative builds on back-to-back kickback complaints by U.S. Attorney Preet Bharara in the Southern District of New York in late April alleging that Swiss pharmaceutical manufacturer Novartis (ADR) engaged in multimillion dollar kickbacks to ...

Novartis AG (ADR) (NYSE:NVS) stock hit highest price at $72.78, beginning with a price of $72.11 and reported a loss of -0.79% to the closed at $72.00 with a day range of $71.98-$72.78.

Let's go over hedge fund and insider activity in other stocks similar to Sanofi SA (ADR) (NYSE:SNY). These stocks are Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Novartis AG (ADR) (NYSE:NVS), GlaxoSmithKline plc (ADR) (NYSE:GSK), and ...

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) purchased rights to develop Synacthen and Synacthen Depot in the United States from Novartis AG (ADR) (NYSE:NVS) in an agreement worth around $135 million, broadening the company's presence in ...

While Novartis AG (ADR) (NYSE:NVS) has had problems with having the drug meet market expectations, Vanda did not suffer a large amount of the financial fall of not having a drug sell.

Earlier this week, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced that it's buying rights to Synacthen from Novartis AG (ADR) (NYSE:NVS) for $135 million plus potential milestone payments. Synacthen is a synthetic form of adrenocorticotropic ...